IMMU-34. A BALANCED TRYPTOPHAN DIET LEADS TO MAXIMAL IMMUNOTHERAPEUTIC EFFICACY IN GLIOBLASTOMA MODELS

INTRODUCTION: Immunotherapy has failed to improve glioblastoma (GBM) patient survival in all Phase III clinical trials to-date. A potential mechanism contributing to treatment failure, is based on our recent work showing that, GBM-infiltrating T cells directly increase the intratumoral expression of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Ladomersky, Erik, Zhai, Lijie, Lenzen, Alicia, Lauing, Kristen, Otto-Meyer, Sebastian, Savoor, Rohan, Lukas, Rimas, Wainwright, Derek
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216321/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.537
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares